BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1257199)

  • 1. [The "problem" of stopping loctation prevention and suppression with CB 154 (author's transl)].
    Schneider D
    Schweiz Rundsch Med Prax; 1976 Jan; 65(2):54-6. PubMed ID: 1257199
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Use of bromocriptin (CB 154) in the treatment of puerperal and pathological lactation" (author's transl)].
    del Pozo E
    Schweiz Rundsch Med Prax; 1976 Feb; 65(7):181-5. PubMed ID: 1250831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic usefulness of bromoergocriptine (CB-154 Sandoz) in patients with galactorrhea (author's transl)].
    González Colindres JA; Canales ES; Levinson G; Zárate A; Sorta J
    Rev Invest Clin; 1975; 27(2):135-8. PubMed ID: 1237173
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and interruption of lactation by a specific nonhormonal inhibitor, bromocriptine (CB 154)].
    Born R; Dequesne J
    Rev Med Suisse Romande; 1977 Jul; 97(7):349-54. PubMed ID: 905714
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
    Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    Scapin F; Buonaccorsi S; Tronconi G; Pellicciotta G; Pontiroli AE
    Eur J Clin Pharmacol; 1982; 22(2):181-3. PubMed ID: 7047172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the onset of lactation. Is cabergoline an alternative to bromocriptine?
    Prescrire Int; 2015 Nov; 24(165):276-7. PubMed ID: 26688910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Bromocriptine--a changing scene.
    Br Med J; 1975 Dec; 4(5998):667-8. PubMed ID: 1239326
    [No Abstract]   [Full Text] [Related]  

  • 10. Bromocriptine in refractory post partum lactation.
    Sathanandan M; Visvanathan T
    Ceylon Med J; 1976 Sep; 21(3):192-3. PubMed ID: 1037476
    [No Abstract]   [Full Text] [Related]  

  • 11. Late suppression of lactation with bromocriptine.
    Benedek-Jaszmann LJ; Sternthal V
    Practitioner; 1976 Apr; 216(1294):450-4. PubMed ID: 775478
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromocriptine update.
    Borowski GD; Rose LI
    Am Fam Physician; 1984 Aug; 30(2):218-20. PubMed ID: 6464960
    [No Abstract]   [Full Text] [Related]  

  • 13. Bromocriptine--an update.
    Schlechte JA
    Iowa Med; 1986 Mar; 76(3):133-5. PubMed ID: 3957620
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine - an important advance.
    Drug Ther Bull; 1976 Apr; 14(9):33-4. PubMed ID: 1278002
    [No Abstract]   [Full Text] [Related]  

  • 15. Disorganized schizophrenia does not deteriorate with dopamine agonists cabergoline and bromocriptine used for ablactation.
    Gahr M; Kölle MA; Freudenmann RW
    Pharmacopsychiatry; 2011 Mar; 44(2):74. PubMed ID: 21157697
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of 2-bromo-alpha-ergocryptine (NSC-169774) in human prostatic cancer.
    Coune A; Smith P
    Cancer Chemother Rep; 1975; 59(1):209-13. PubMed ID: 1093667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of bromocryptin--Richter for the suppression of the onset of lactation after the interruption of pregnancy between the 14th and 28th gestational weeks--a preliminary report].
    Marinov B; Tsankova M; Damianov L
    Akush Ginekol (Sofiia); 1999; 38(4):56-8. PubMed ID: 10726358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: The many faces of bromocriptine.
    Vaisurb S
    JAMA; 1976 Jun; 235(26):2854-5. PubMed ID: 946996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinson disease with Bromocriptine (CB 154 Sandoz) (author's transl)].
    Jacobides GB; Audibert A
    Ther Umsch; 1975 Jul; 32(7):469-71. PubMed ID: 1105868
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
    Stracke H; Heinlein W; Horowski R; Schatz H
    Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.